Amelioration of vincristine neurotoxicity by glutamic acid.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  American Journal of Medicine

• Publication date

  1988-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0002-9343(88)90306-3PMID 2897788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical trial of pyridoxine to reduce vincristine neurotoxicity

  2005cited by this paper
• A sensitive radioimmunoassay for vincristine and vinblastine

  2004cited by this paper
• Clinical trial of folinic acid to reduce vincristine neurotoxicity

  2004cited by this paper
• Treatment of vincristine-induced ileus with sincalide, a cholecystokinin analog

  2004cited by this paper
• Vinca alkaloid-induced cardiovascular autonomic neuropathy.

  1985cited by this paper
• Metoclopramide in vincristine-induced ileus.

  1985cited by this paper
• Glutamic acid modification of vincristine toxicity.

  1984cited by this paper
• Improved tolerance of vincristine by glutamic acid. A preliminary report.

  1984cited by this paper
• Chronic biliary sampling via a subcutaneous system in dogs.

  1982cited by this paper
• Neurotoxicity of antineoplastic drugs.

  1982cited by this paper
• Massive vincristine overdose: failure of leucovorin to reduce toxicity.

  1982cited by this paper
• Subacute vincristine toxicity following five consecutive daily doses

  1982cited by this paper
• Intravenous vincristine infusion: Phase I trial

  1981cited by this paper
• Glutamate-induced polymerization of tubulin: characteristics of the reaction and application to the large-scale purification of tubulin.

  1981cited by this paper
• Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.

  1981cited by this paper
• Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.

  1980cited by this paper
• Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.

  1980cited by this paper
• Folinic acid rescue for vincristine toxicity.

  1979cited by this paper
• Clinical pharmacology of anti-neoplastic drugs

  1978cited by this paper
• Biliary excretion of vincristine

  1978cited by this paper
• Overdosage with vincristine.

  1976cited by this paper
• Pharmacological studies with vinblastine in the dog.

  1975cited by this paper
• Vinca Alkaloids and Colchicine

  1975cited by this paper
• Uptake and binding of vincristine by murine leukemia cells.

  1975cited by this paper
• Inappropiate ADH secretion associated with massive vincristine overdosage.

  1975cited by this paper
• Neurotoxicity of commonly used antineoplastic agents (first of two parts).

  1974cited by this paper
• Vincristine neurotoxicity.

  1974cited by this paper
• Colchicine, vinblastine and griseofulvin. Pharmacological studies with human leukocytes.

  1971cited by this paper
• Cytological and clinical observations during vincaleukoblastine therapy of disseminated cancer

  1962cited by this paper
• Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate.

  1962cited by this paper

• Inadvertent intrathecal application of vindesine and its neurological outcome: case report and systematic review of the literature

  2025cites this paper
• Successful management and recovery of a dog with immune‐mediated thrombocytopenia following vincristine overdose

  2022cites this paper
• Neuroprotective effect of vitamin B6 and vitamin B12 against vincristine- induced peripheral neuropathy: A randomized, double- blind, placebo controlled, multicenter trial

  2021cites this paper
• Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment

  2021cites this paper
• Full title: Neuroprotective effect of vitamin B 6 and vitamin B 12 against vincristine- induced peripheral neuropathy: A randomized, double- blind, placebo controlled, multicenter trial

  2021cites this paper
• Pharmacological Treatment of Established Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations

  2020cites this paper
• Chapter 34 : Colchicine , Podophyllin , and the Vinca Alkaloids

  2019cites this paper
• Oesophageal narrowing during combination chemotherapy in Ewing’s sarcoma: Is vincristine a culprit?

  2018cites this paper
• Antitubulin agents: Colchicine, vinca alkaloids, and podophyllin

  2017cites this paper
• Nutritional Modulators in Chemotherapy-Induced Neuropathic Pain

  2017cites this paper
• Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy

  2017cites this paper
• Chemotherapy‐mediated pain and peripheral neuropathy: impact of oxidative stress and inflammation

  2016cites this paper
• Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer

  2015cites this paper
• Intrathecal Chemotherapy: Potential for Medication Error

  2014cites this paper
• Accidental Intrathecal Administration of Vincristine in Pediatric Patients

  2013cites this paper
• Glutamic acid and its derivatives: candidates for rational design of anticancer drugs.

  2013cites this paper
• Synthesis and Biological Evaluation of 5-N-substituted-2(substituted naphthalenesulphonyl) L (+) Glutamine as Possible Anticancer Agents

  2013cites this paper
• Leukaemia update. Part 2: managing patients with leukaemia in the community

  2013cites this paper
• Neurological complications of chemotherapy to the peripheral nervous system.

  2012cites this paper
• Neurotoxic Complications of Chemotherapy in Patients with Cancer

  2012cites this paper
• Principes d’oncogériatrie

  2011cites this paper
• Management in Neuro-Oncology

  2011cites this paper
• Vincristine-induced unilateral ptosis with serendipitous response to modafinil

  2011cites this paper
• Constipation.

  2011cites this paper
• Mediastinal mass and paraparesis as the sole presenting features of Langerhans cell histiocytosis.

  2010cites this paper
• Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".

  2010cites this paper
• A Trial to Assess the Efficacy of Glutamic Acid in Prevention of Vincristine-induced Neurotoxicity in Pediatric Malignancies: A Pilot Study

  2010influential citation
• Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.

  2010cites this paper
• Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.

  2009cites this paper
• Effect of Gosha-jinki-gan on vincristine-induced painful neuropathy in mice

  2008cites this paper
• Utvikling av en analysemetode for vinkristin i plasma

  2007cites this paper
• Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.

  2007cites this paper
• Review of case reports of inadvertent intrathecal administration of vincristine: Recommendations to reduce occurrence

  2007cites this paper
• Particularités de l’usage des agents cytotoxiques chez le sujet âgé

  2007cites this paper
• Geriatrische Onkologie, eine Herausforderung der Zukunft

  2007cites this paper
• Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

  2007influential citation
• Linfoma não-Hodgkin difuso de grandes células B : características clínicas, tratamento e prognóstico com os esquemas quimioterápicos CHOP e CHOP-Bleo

  2006cites this paper
• Effect of mexiletine on vincristine-induced painful neuropathy in mice.

  2006cites this paper
• Glutamate Ameliorates Experimental Vincristine Neuropathy 1

  2006cites this paper
• NEUROMUSCULAR DISEASE | Lower Motor Neuron Diseases

  2006cites this paper
• Activation of cannabinoid CB1 and CB2 receptors suppresses painful peripheral neuropathy evoked by the chemotherapeutic agent vincristine

  2006cites this paper
• Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine‐induced painful neuropathy in mice

  2005cites this paper
• L-Glutamic acid and glutamine: Exciting molecules of clinical interest

  2005cites this paper
• L-Glutamic acid and glutamine: Exciting molecules of clinical -Glutamic acid and glutamine: Exciting molecules of clinical -Glutamic acid and glutamine: Exciting molecules of clinical -Glutamic acid and glutamine: Exciting molecules of clinical -Glutamic acid and glutamine: Exciting molecules of cli

  2005cites this paper
• Chronic constipation in children: Organic disorders are a major cause

  2005cites this paper
• Amelioration of Experimental Cisplatin and Paclitaxel Neuropathy with Glutamate

  2004cites this paper
• Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells

  2004cites this paper
• Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug

  2004cites this paper
• Brain injury: current management and investigations.

  2003cites this paper
• [Chemotherapeutic neurotoxicity].

  2003cites this paper
• Dose-dependent effects of glutamate in pyridoxine-induced neuropathy.

  2003cites this paper
• Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy.

  2003cites this paper
• Sexual dimorphism for protein kinase cε signaling in a rat model of vincristine-induced painful peripheral neuropathy

  2003cites this paper
• ビンクリスチン投与により顕性化したCharcot-Marie-Tooth病1A型の1例

  2003cites this paper
• [Malignant diseases in the elderly. The elderly tumor patient].

  2002cites this paper
• Intrathecal Vincristine: Fatal Myeloencephalopathy Despite Cerebrospinal Fluid Perfusion

  2002cites this paper
• Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia

  2002cites this paper
• ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature

  2001cites this paper
• Peripheral Neuropathy in Cancer Patients

  2001cites this paper
• Chemotherapy-evoked painful peripheral neuropathy.

  2001cites this paper
• Peripheral neuropathy in cancer patients.

  2001cites this paper
• Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report.

  2000cites this paper
• Drug-Associated Diarrhoea and Constipation in Older People

  2000cites this paper
• Drug-sssociated diarrhoea and constipation in older people. 2. Constipation

  2000cites this paper
• Potential Salvage Therapy for Accidental Intrathecal Vincristine Administration: A Preliminary Experimental Study

  2000cites this paper
• Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection

  1999cites this paper
• Complications neurologiques des chimiothérapies

  1999cites this paper
• Vincristine revisited.

  1999cites this paper
• [Neurologic complications of chemotherapy].

  1999cites this paper
• Nerve lesions after therapy for childhood acute lymphoblastic leukemia

  1998cites this paper
• Neuropathies Associated with Malignancy

  1998cites this paper
• Fatality resulting from intraventricular vincristine administration.

  1998cites this paper
• Cancer Chemotherapy in Older Adults

  1997cites this paper
• Errors involving pediatric patients receiving chemotherapy: a literature review.

  1997cites this paper
• Potential salvage therapy for inadvertent intrathecal administration of vincristine

  1997cites this paper
• Cancer chemotherapy in the older patient

  1997cites this paper
• Errors involving pediatric patients receiving chemotherapy: a literature review.

  1997cites this paper
• Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

  1996cites this paper
• Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans.

  1996cites this paper
• 16 – Anticancer drugs and immunomodulators

  1996cites this paper
• Glutamate ameliorates experimental vincristine neuropathy.

  1996cites this paper
• In vivo modulation of vincristine-induced neurotoxicity in Lymnaea stagnalis, by the ACTH(4–9)analogue Org 2766

  1996cites this paper
• Reducing chemotherapy-associated toxicity in elderly cancer patients.

  1996cites this paper
• Clinical Neurotoxic Concerns on Antineoplastic Agents

  1995cites this paper
• [Drug-induced neurological complications in a hospital cohort].

  1995cites this paper
• Acute and Late Toxicity on Peripheral Nerves After Chemotherapy — A Review

  1995cites this paper
• Phantom limb pain and chemotherapy in pediatric amputees.

  1995cites this paper
• Neurotoxicity secondary to antineoplastic drugs.

  1994cites this paper
• Vincristine without a cap? So …

  1994cites this paper
• Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

  1994cites this paper
• Prevention and treatment of organ toxicity during high-dose chemotherapy: an overview.

  1993cites this paper
• Chemotherapy made easier.

  1993cites this paper
• Chemotherapy of malignant brain tumors in children.

  1992cites this paper
• Antimitotics in cancer chemotherapy

  1992cites this paper
• Lesions of the Peripheral Nervous System

  1992cites this paper
• Current research in side effects of high-dose chemotherapy.

  1992cites this paper
• A pilot study on the influence of a corticotropin (4-9) analogue on Vinca alkaloid-induced neuropathy.

  1992cites this paper
• The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

  1991cites this paper
• Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses.

  1991cites this paper